A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2006
11/01/2006	CN1853677A Chinese medicine for heart disease
11/01/2006	CN1853674A Quality controlling method of Xingdan injection
11/01/2006	CN1853673A Quality controlling method of double-Danshen injection
11/01/2006	CN1853672A Composition containing butylbenzene peptide
11/01/2006	CN1853671A Thrombolytic collaterals-activating preparation for treating angiitis and phlebitis and making method thereof
11/01/2006	CN1853670A Coronary heart Danshen root micropellets and preparation thereof
11/01/2006	CN1853660A Erigeron breviscapus preparation and making method thereof
11/01/2006	CN1853659A Xinnao Shutong soft capsule and preparation thereof
11/01/2006	CN1853651A Medicinal composition containing cinnabar or/and realgar
11/01/2006	CN1853643A Composition of self-microemulsion puerarin oral preparation and use thereof
11/01/2006	CN1853637A Use of pentacyclic triterpene compound as glycogen phosphorylase inhibitor
11/01/2006	CN1853624A Fat emulsion containing tanshinone analog and use thereof
11/01/2006	CN1853617A Medicine based on anti-hyperglycaemic microcapsules with prolonged release
11/01/2006	CN1853505A Edible ginkgo pollen
11/01/2006	CN1282649C Corter pseudolaricis acid derivatives, preparation method and use thereof
11/01/2006	CN1282644C Indane or indoline derivative
11/01/2006	CN1282643C Intermediate for preparing compounds having serotonin-2 receptor antagonistic and alpha-1 blocking action and its preparing method
11/01/2006	CN1282484C Lipid reducing and regulating agent
11/01/2006	CN1282473C Wild chrysanthemum granules and preparation method
11/01/2006	CN1282468C Chinese medicine soft capsule Naodesheng and its preparing method
11/01/2006	CN1282467C Medicine for treating coronary disease and stenocardia and its preparation method
11/01/2006	CN1282464C Chinese medicinal preparation and preparing method for chronic heart fatilue
11/01/2006	CN1282461C Trichosanthes peel injection and its preparation method
11/01/2006	CN1282457C Composite for treating hyperlipidemia
11/01/2006	CN1282419C 油组合物 Oil composition
10/2006
10/31/2006	US7129379 3-amino-propoxphenyl derivatives (l)
10/31/2006	US7129356 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives
10/31/2006	US7129352 Reacting with sodium hydroxide then calcium chloride to form calcium salt derivative; 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors
10/31/2006	US7129272 Apoptosis inhibitor
10/31/2006	US7129270 Antiinflammatory agents
10/31/2006	US7129258 Substituted benzoxazoles as estrogenic agents
10/31/2006	US7129255 Substituted 2-carba-3,5-dicyano-4-aryl-6-aminopyridines and the use of the same as selective ligands of the adenosine receptor
10/31/2006	US7129253 Compounds
10/31/2006	US7129249 Heterocyclic amide derivatives as inhibitors of glycogen phoshorylase
10/31/2006	US7129247 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
10/31/2006	US7129246 N-adamantlmethyl derivatives and intermediates as pharmaceutical compositions and processes for their preparation
10/31/2006	US7129245 Anticoagulants which act selectively on factor Xa; fast acting; oral; do not interfere with lysis of blood clots
10/31/2006	US7129243 Respiratory system disorders; cardiovascular disorders; antidiabetic agents; antiarthritic agents; antiinflammatory agents; immunosuppressants
10/31/2006	US7129242 Such as 4-((4-chlorophenyl)pyrimidin-2-yl)amino)benzamide; for treatment of inflammation/autoimmune conditions
10/31/2006	US7129241 Pyridazine derivatives
10/31/2006	US7129240 1,3-dihydro-2H-indol-2one derivatives, process for preparing them and pharmaceutical compositions containing them
10/31/2006	US7129236 For therapy of immune related responses, tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis
10/31/2006	US7129219 enhance humoral and cell-mediated immune responses to vaccine antigens; 2-deoxy-2-amino- beta -D-glucopyranose (glucosamine) glycosidically linked to an cyclic aminoalkyl (aglycon) group
10/31/2006	US7129064 Canine hepatocyte growth factor
10/31/2006	US7129034 Culturing stem cell with fibroblast growth factor and epidermal growth factor
10/31/2006	US7128905 methods of preventing and treating diseases wherein the involvement of apoptosis has been indicated.
10/31/2006	US7128896 using carbocyanine dyes; photodynamic therapy; in vivo supplying to tumor
10/31/2006	CA2355886C Substituted oximes and hydrazones as neurokinin antagonists
10/31/2006	CA2333405C Spill resistant pharmaceutical compositions
10/31/2006	CA2186508C Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors
10/31/2006	CA2136953C A method for using lipoprotein associated coagulation inhibitor to treat sepsis
10/26/2006	WO2006113942A2 Method of inhibiting cathepsin activity
10/26/2006	WO2006113864A2 Oxindole compounds and their uses as therapeutic agents
10/26/2006	WO2006113247A1 Use of tafi inhibitors for enhanced myocardial reperfusion and facilitated pci
10/26/2006	WO2006112772A1 Combination product
10/26/2006	WO2006112390A1 Fat-derived progenitor cell and use thereof
10/26/2006	WO2006112379A1 Drug for treating or diagnosing vascular lesion in the skin or the subcutaneous soft tissue caused by light irradiation
10/26/2006	WO2006112364A1 Hypotensive agent produced by cultivation of lactic acid bacterium
10/26/2006	WO2006111757A2 Animal model of vascular smooth muscle cell apoptosis
10/26/2006	WO2006111495A1 Roflumilast for the treatment of pulmonary hypertension
10/26/2006	WO2006111424A1 Methods for identifying modulators of cb1 and cb2 cannabinoid receptors and their use in wound healing
10/26/2006	WO2006111351A1 Use of a biological active blood serum for the treatment of stroke
10/26/2006	WO2006111085A1 A method, formulation and use thereor with improved oral absorption of drugs or nutrients
10/26/2006	WO2006021399A3 Azabicyclononene derivatives as renin inhibitors
10/26/2006	WO2005048976A3 Foams comprising a sclerosing and a viscosity enhancing agent, methods for production thereof
10/26/2006	WO2002100445A8 Treatment and composition for wound healing
10/26/2006	US20060242716 Disease model animal carrying foreign ppar alpha gene transferred thereinto and use thereof
10/26/2006	US20060241299 Process for making spirolactone compounds
10/26/2006	US20060241181 Alpha-ketoglutarates of active ingredients and compositions containing same
10/26/2006	US20060241171 Novel physiologically active substances
10/26/2006	US20060241157 Heterocyclic ppar modulators
10/26/2006	US20060241147 Pyridine derivatives useful for inhibiting sodium/calcium exchange system
10/26/2006	US20060241142 Naphthamide derivatives and their use
10/26/2006	US20060241138 Heterocyclic amide derivatives for the treatment of diabetes and other diseases
10/26/2006	US20060241127 N-[2-Amino-6-(4-pyridinyl)-4-pyrimidinyl]-N-[2-fluoro-4-(1H-pyrrolo[2,3-b]-pyridin-4-yloxy)phenyl]amine, used for the treatment and/or prophylaxis of cardiovascular diseases and erectile dysfunction
10/26/2006	US20060241126 Phospholipase inhibitors perticularly phospholipase A2 enzyme Lipoprotein Associated Phospholipase A2; N-(1-Methylpiperidin-4-yl)-(2-(2-(2,3-difluorophenyl)ethyl)-4-oxo-4H-pyrido[2,3-d]pyrimidin-1-yl)-N-(4-(4-trifluoromethylphenyl)phenyl)methylacetamide; amidation
10/26/2006	US20060241116 affinity for peripheral-type benzodiazepine receptors; in vitro and in vivo affinity; chemical intermediates
10/26/2006	US20060241113 Polyarylcarboxamides useful as lipid lowering agents
10/26/2006	US20060241096 Agent for preventing or treating organ functional disorders and organ dysfunction
10/26/2006	US20060241089 Dipyridamole, acetylsalicylic acid, and angiotensin II antagonist pharmaceutical compositions
10/26/2006	US20060241085 Compounds having anti-proliferative properties
10/26/2006	US20060241068 Cardiac failure, cardiomegaly, myocarditis, cardiomyopathy, arteriosclerosis, arteriosclerosis obliterans, or ischemic heart disease
10/26/2006	US20060241054 Growth hormone-releasing peptides in the treatment of prevention of atherosclerosis and hypercholesterolemia
10/26/2006	US20060241051 Metastin derivatives and use thereof
10/26/2006	US20060240525 Factor VII or VIIa - Like Molecules
10/26/2006	US20060240524 Conjugate comprising polypeptide with N-glycosylation site and sugar; increase blood clot formation for treatment of thrombocytopenia and hemophilia
10/26/2006	US20060240113 Anticancer agents; prevent forming blood vessels; removal blockager
10/26/2006	US20060240095 Pharmaceutical composition comprising a combination of metformin and a statin
10/26/2006	US20060240086 Adhesive patch
10/26/2006	US20060240023 Apoptosis-associated protein and use thereof
10/26/2006	US20060240010 Methods of modulating CD200 receptors
10/26/2006	US20060239990 Protein Arginine N-Methyltransferase 2 (PRMT-2)
10/26/2006	US20060239985 Method of preparing cell for transplantation
10/26/2006	US20060239959 Method for treating hypercholesterolemia with polyallylamine polymers
10/26/2006	US20060239926 Specific high-relaxivity compounds
10/26/2006	US20060239915 Labeled macrophage scavenger receptor antagonists for imaging cardiovascular diseases
10/26/2006	US20060239912 Carrier molecules
10/26/2006	US20060237004 Methods for treating trigeminal neuralgia
10/26/2006	US20060237003 Methods for treating headaches
10/26/2006	DE4244539B4 Duale Inhibitoren der No-Synthese und Cyclooxygenase, Verfahren zu ihrer Herstellung und therapeutische Präparate, die sie enthalten Dual inhibitors of NO synthesis and cyclooxygenase, processes for their preparation and therapeutic compositions containing them

1 ... 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 ... 1595